Evidence map›Paper›PMID 31134411›Full record

Observational studyJournal of assisted reproduction and genetics2019

The main will of the patients of a private Italian IVF clinic for their aneuploid/affected blastocysts would be donation to research: a currently forbidden choice.

Federica Faustini, Marina Forte, Antonio Capalbo, Danilo Cimadomo, Filippo Maria Ubaldi, Laura Rienzi

Abstract readObservational Study
In one paragraph

Observational study in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Federica FaustiniG.EN.E.R.A. Centers for Reproductive Medicine, Clinica Valle Giulia, via G. de Notaris 2/b, 00197, Rome, Italy. psicologia@generaroma.it.ORCID http://orcid.org/0000-0001-8953-8023
Marina ForteG.EN.E.R.A. Centers for Reproductive Medicine, Clinica Valle Giulia, via G. de Notaris 2/b, 00197, Rome, Italy.
Antonio CapalboIgenomix, Marostica (VI), Italy.
Danilo CimadomoG.EN.E.R.A. Centers for Reproductive Medicine, Clinica Valle Giulia, via G. de Notaris 2/b, 00197, Rome, Italy.
Filippo Maria UbaldiG.EN.E.R.A. Centers for Reproductive Medicine, Clinica Valle Giulia, via G. de Notaris 2/b, 00197, Rome, Italy.
Laura RienziG.EN.E.R.A. Centers for Reproductive Medicine, Clinica Valle Giulia, via G. de Notaris 2/b, 00197, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSurplus cryopreserved affected/aneuploid blastocysts may be obtained after in vitro fertilization (IVF) treatments with preimplantation genetic testing (PGT). These embryos are considered not suitable for transfer and may be discarded. Currently, in Italy, an embryo disposition decision (EDD) is not allowed and the frozen/vitrified blastocysts (even if affected/aneuploid) should be kept cryopreserved indefinitely. In this peculiar clinical, social, and legislative scenario, we aimed at assessing the attitudes of the patients towards the fate of these embryos, in case the local regulation would be changed and allow an EDD regarding the surplus affected/aneuploid embryos obtained after PGT.

methodsA questionnaire with multiple answers was submitted to 832 patients who obtained affected/aneuploid embryos during a PGT cycle at our private IVF center. They were asked to choose between three putative options with related reasons: everlasting cryopreservation (only option currently available); discard or donate them to research.

resultsOverall, 149 patients (18%; 85 women and 64 men) answered the questionnaire. Among them, 84% (n = 126) would choose to donate their affected/aneuploid blastocysts to research, 9% (n = 13) would discard them and only 7% (n = 10) would keep them cryopreserved indefinitely.

conclusionsDonation of the affected/aneuploid blastocysts is the option chosen from most of the respondents (84%; 15% of the eligible patients). These patients are motivated from the altruistic will of incentivating the progress in IVF and/or stem cell research and supporting future couples to limit/solve their infertility/health issues.

Indexed as

AneuploidyBlastocystDecision MakingAdultCohort StudiesEmbryo DispositionEmbryo, MammalianEmbryo ResearchFemaleFertilization in VitroHumansInfertilityMalePatientsSurveys and QuestionnairesTissue and Organ ProcurementAffected embryosDonationEmbryo disposition decisionPreimplantation genetic testingSurplus embryos

Identifiers

PMID31134411
PMCPMC6708053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.